New York State Common Retirement Fund Acadia Pharmaceuticals Inc Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 51,374 shares of ACAD stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,374
Previous 51,374
-0.0%
Holding current value
$1.24 Million
Previous $853,000
29.89%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ACAD
# of Institutions
346Shares Held
165MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.04 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$369 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$292 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$218 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$150 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.92B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...